Insights into the workings of an immune cell surface receptor, called PD-1, reveal how treatments that restrict its action can potentially be strengthened to improve their anticancer effect, a new ...
JUPITER, Fla.--(BUSINESS WIRE)--BlinkBio Inc., a privately held, biotechnology company, today announced that it has entered into a collaboration agreement with Janssen Pharmaceuticals Inc., in the ...
Company to Pursue Applications in Rare Diseases and Proprietary Medical Food Domains Deal Unlocks Opportunities for Future Collaborations SAN FRANCISCO--(BUSINESS WIRE)--DIMERx, Inc., an advance-stage ...
Explore how mass photometry delivers absolute mass measurements in native buffers across three protein systems ...
A study reported by researchers at NYU Langone Health’s Perlmutter Cancer Center and at the University of Oxford has offered up new insights into the workings of an immune cell surface receptor, ...
Thousands of times per year, a family's moment of joy turns to unexpected grief. A seemingly healthy infant stops smiling or making eye contact. Their ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results